The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Emergence and management of drug-resistant enterococcal infections
Abstract
The treatment of multidrug-resistant enterococcal infections continues to be a challenge for clinicians. Glycopeptide and beta-lactam resistance is now a common feature of the majority of Enterococcus faecium hospital isolates, and resistance to aminoglycosides, quinupristin-dalfopristin, linezolid and daptomycin further complicates the problem. New antibiotics, such as tigecycline, lipoglycopeptides (dalbavancin, oritavancin and telavancin) and cephalosporins with activity against Enterococcus faecalis (ceftobiprole and ceftaroline), may have potential activity against certain resistant enterococcal strains in specific clinical settings, as may some older antibiotics, such as ampicillin, chloramphenicol, doxycycline, minocycline and nitrofurantoin. However, the treatment of endovascular infections (particularly endocarditis, where bactericidal therapy is important for optimal cure rates) caused by resistant enterococci continues to be an immense challenge even with the availability of new agents. The optimal therapy for these infections is not well established and clinical data are usually limited to case reports with conflicting results. Therefore, treatment decisions may have to be based on animal models and sporadic experiences and the best approach is for the physician to consider carefully each patient on a case by case manner and gather all the clinical and microbiological information possible regarding species identification and susceptibilities in order to choose a therapeutic regimen that would appear to be active.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Self-citationGenetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 694
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Ribosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Cui, L., Tominaga, E., Neoh, H.-M., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Ellis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Recent advances in the formation of the bacterial peptidoglycan monomer unit (1985 to 2000)
Heijenoort, J. V. (2001) · Natural Product Reports · doi:10.1039/a804532a · Cited by 408
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions
Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M., Dunyak, D. S., Demyan, W. F., & Buysse, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2132 · Cited by 384
Babinchak, T., Ellis‐Grosse, E., Dartois, N., Rose, G. M., Loh, E., & Groups, T. 3. A. 3. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431676 · Cited by 381
Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 357
Deshpande, L. M., Fritsche, T. R., Moet, G. J., Biedenbach, D. J., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.12.022 · Cited by 345
Schwarz, S., Werckenthin, C., & Kehrenberg, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2530-2533.2000 · Cited by 341
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Self-citationDihydrofolate reductase inhibitors as antibacterial agents
Hawser, S., Lociuro, S., & Islam, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.052 · Cited by 335
Kehrenberg, C., Schwarz, S., Jacobsen, L., Hansen, L. H., & Vester, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04754.x · Cited by 333
Aminoglycoside Resistance in Enterococci
Chow, J. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313949 · Cited by 332
Willems, R. J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D., Manzioros, X., Gaillard, C., Vandenbroucke-Grauls, C. M., Mascini, E. M., van Kregten, E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04205-7 · Cited by 327
Development of daptomycin for Gram-positive infections
Tally, F. P., & DeBruin, M. F. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.523 · Cited by 321
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-07 · Cited by 318
Jauregui, L. E., Babazadeh, S., Seltzer, E., Goldberg, L., Krievins, D., Frederick, M., Krause, D., Satilovs, I., Endzinas, Z., Breaux, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497271 · Cited by 312
Drees, M., Snydman, D. R., Schmid, C. H., Barefoot, L., Hansjosten, K., Vue, P. M., Cronin, M., Nasraway, S. A., & Golan, Y. (2008) · Clinical Infectious Diseases · doi:10.1086/527394 · Cited by 307
Prystowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R., & Noskin, G. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2154-2156.2001 · Cited by 302
Tigecycline: A Critical Analysis
Stein, G. E., & Craig, W. A. (2006) · Clinical Infectious Diseases · doi:10.1086/505494 · Cited by 298
Stryjewski, M. E., Graham, D. R., Wilson, S. E., O’Riordan, W., Young, D., Lentnek, A., Ross, D. P., Fowler, V. G., Hopkins, A., Friedland, H. D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587896 · Cited by 289
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 276
Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy
Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., & Pagès, J.-M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl493 · Cited by 270
McOsker, C. C., & Fitzpatrick, P. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.suppl_a.23 · Cited by 268
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
Self-citationGene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
Nosocomial Infection by Gentamicin-Resistant Streptococcus faecalis: An Epidemiologic Study
ZERVOS, M. J., KAUFFMAN, C. A., THERASSE, P. M., BERGMAN, A. G., MIKESELL, T. S., & SCHABERG, D. R. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-687 · Cited by 261
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Top, J., Willems, R., & Bonten, M. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00383.x · Cited by 260
Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D., & Kusne, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.663 · Cited by 259
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
VanD-type glycopeptide-resistant Enterococcus faecium BM4339
Perichon, B., Reynolds, P., & Courvalin, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2016 · Cited by 244
Nosocomial Spread of Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium
Herrero, I. A., Issa, N. C., & Patel, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200203143461121 · Cited by 241
VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405
Fines, M., Perichon, B., Reynolds, P., Sahm, D. F., & Courvalin, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2161 · Cited by 241
Risk of Infection Due to Central Venous Catheters: Effect of Site of Placement and Catheter Type
Goetz, A. M., Wagener, M. M., Miller, J. M., & Muder, R. R. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647742 · Cited by 230
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 226
Moellering, R. C., Linden, P. K., Reinhardt, J., Blumberg, E. A., Bompart, F., & Talbot, G. H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.251 · Cited by 218
Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetX
Moore, I. F., Hughes, D. W., & Wright, G. D. (2005) · Biochemistry · doi:10.1021/bi0506066 · Cited by 217
High-Level Resistance to Gentamicin in Clinical Isolates of Enterococci
Mederski-Samoraj, B. D., & Murray, B. E. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.4.751 · Cited by 213
Self-citationMechanism of action of the oxazolidinone antibacterial agents
Shinabarger, D. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1195 · Cited by 211
Anthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy
Sabol, K., Patterson, J. E., Lewis, J. S., Owens, A., Cadena, J., & Jorgensen, J. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1664-1665.2005 · Cited by 209
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00008 · Cited by 202
Lucas, G. M., Lechtzin, N., Puryear, D. W., Yau, L. L., Flexner, C. W., & Moore, R. D. (1998) · Clinical Infectious Diseases · doi:10.1086/520311 · Cited by 195
16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium
Ross, J. I., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1702 · Cited by 194
Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women
Gupta, K. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2207 · Cited by 192
Chien, J. W., Kucia, M. L., & Salata, R. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313597 · Cited by 190
Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.
Rc, M., Wennersten, C. B., & Weinberg, A. N. (1971) · PubMed · Cited by 186
Novel Mechanism of β-Lactam Resistance Due to Bypass of DD-Transpeptidation in Enterococcus faecium
Mainardi, J., Legrand, R., Arthur, M., Schoot, B. M., van HEIJENOORT, J., & Gutmann, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909877199 · Cited by 182
Akins, R. L., & Rybak, M. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.454-459.2001 · Cited by 179
Enterococcus faecium Bacteremia: Does Vancomycin Resistance Make a Difference?
Stosor, V., Peterson, L. R., Postelnick, M., & Noskin, G. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.522 · Cited by 176
Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline
Trieber, C. A., & Taylor, D. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2131-2140.2002 · Cited by 174
Harms, J. M., Schlünzen, F., Fucini, P., Bartels, H., & Yonath, A. (2004) · BMC Biology · doi:10.1186/1741-7007-2-4 · Cited by 171
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl219 · Cited by 167
Falagas, M. E., Siempos, I. I., & Vardakas, K. Z. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70312-2 · Cited by 166
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis
Mainardi, J. L., Gutmann, L., Acar, J. F., & Goldstein, F. W. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1984 · Cited by 164
DiazGranados, C. A., & Jernigan, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427512 · Cited by 160
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
Salgado, C. D., & Farr, B. M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502271 · Cited by 159
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156
Munoz-Price, L. S., Lolans, K., & Quinn, J. P. (2005) · Clinical Infectious Diseases · doi:10.1086/432121 · Cited by 155
Williams, D. H., Searle, M. S., Mackay, J. P., Gerhard, U., & Maplestone, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1172 · Cited by 152
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited
Depardieu, F., Bonora, M. G., Reynolds, P. E., & Courvalin, P. M. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03737.x · Cited by 151
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
Candiani, G., Abbondi, M., Borgonovi, M., Romanò, G., & Parenti, F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.179 · Cited by 150
Mechanism of Action of Streptogramins and Macrolides
Vannuffel, P., & COCITO, C. G. (1996) · Drugs · doi:10.2165/00003495-199600511-00006 · Cited by 147
16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., de Zoete, M. R., Arents, N. L. A., Kuipers, E. J., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2996-3000.2002 · Cited by 137
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castañeda, E., Villegas, M. V., Murray, B. E., & Quinn, J. P. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01886-07 · Cited by 135
Self-citationBoyd, D. A., Willey, B. M., Fawcett, D., Gillani, N., & Mulvey, M. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-07 · Cited by 135
Effect of protein binding of daptomycin on MIC and antibacterial activity
Lee, B. L., Sachdeva, M., & Chambers, H. F. “. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2505 · Cited by 133
Lewis, R. E., Wiederhold, N. P., & Klepser, M. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.945-951.2005 · Cited by 129
Rahim, S., Pillai, S. K., Gold, H. S., Venkataraman, L., Inglima, K., & Press, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/374929 · Cited by 129
Fontana, R., Aldegheri, M., Ligozzi, M., López, H. M., Sucari, A., & Satta, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1980 · Cited by 125
Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936)
Hirata, T., Saito, A., Nishino, K., Tamura, N., & Yamaguchi, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2179-2184.2004 · Cited by 124
Heat and chemical resistance of enterococci
Bradley, C. R., & Fraise, A. P. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90065-1 · Cited by 124
Preclinical Pharmacology of GAR‐936, a Novel Glycylcycline Antibacterial Agent
Projan, S. J. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.14.219s.35046 · Cited by 123
Dandekar, P. K., Tessier, P. R., Williams, P., Nightingale, C. H., & Nicolau, D. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg337 · Cited by 119
Treatment of enterococcal endocarditis and bacteremia
Robbins, W. C., & Tompsett, R. R. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90273-2 · Cited by 117
Zhu, W., Clark, N. C., McDougal, L. K., Hageman, J., McDonald, L. C., & Patel, J. B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00908-07 · Cited by 117
vanC Cluster of Vancomycin-Resistant Enterococcus gallinarum BM4174
Arias, C. A., Courvalin, P. M., & Reynolds, P. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1660-1666.2000 · Cited by 115
Self-citationNicas, T. I., MULLEN, D. L., Flokowitsch, J. E., Preston, D. A., SNYDER, N. J., Zweifel, M. J., Wilkie, S. C., Rodriguez, M. J., Thompson, R. C., & Cooper, R. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2194 · Cited by 114
King, A., Phillips, I., & Kaniga, K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh156 · Cited by 114
Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid
Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S. (2001) · Clinical Infectious Diseases · doi:10.1086/319986 · Cited by 113
Mechanism of Resistance to Antibiotic Synergism in Enterococci
Zimmermann, R. A., Moellering, R. C., & Weinberg, A. N. (1971) · Journal of Bacteriology · doi:10.1128/jb.105.3.873-879.1971 · Cited by 112
A novel gentamicin resistance gene in Enterococcus
Chow, J. W., Zervos, M., Lerner, S. A., Thal, L. A., Donabedian, S. M., Jaworski, D. D., Tsai, S., Shaw, K. J., & Clewell, D. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.511 · Cited by 109
Aminoglycoside-Inactivating Enzymes in Clinical Isolates of Streptococcus Faecalis
Krogstad, D. J., Korfhagen, T. R., Moellering, R. C., Wennersten, C. B., Swartz, M. N., Perzyński, S., & DAVIES, J. E. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109149 · Cited by 100
Lautenbach, E., Schuster, M. G., Bilker, W. B., & Brennan, P. J. (1998) · Clinical Infectious Diseases · doi:10.1086/515002 · Cited by 100
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall
Krogstad, D. J., & Pargwette, A. R. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.6.965 · Cited by 100
Nallapareddy, S. R., Huang, W., Weinstock, G. M., & Murray, B. E. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.16.5709-5718.2005 · Cited by 98
Self-citationDalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
Saravolatz, L. D., Billeter, M., Zervos, M., Chen, A. Y., Dalovisio, J. R., & Kurukularatne, C. (2008) · Clinical Infectious Diseases · doi:10.1086/526772 · Cited by 96
Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
Kainer, M. A., Devasia, R. A., Jones, T. F., Simmons, B. P., Melton, K., Chow, S., Broyles, J., Moore, K. L., Craig, A. S., & Schaffner, W. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.070019 · Cited by 96
Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin
Linden, P. K., Moellering, R. C., Wood, C. A., Rehm, S. J., Flaherty, J. P., Bompart, F., Talbot, G. H., & Synercid Emergency‐Use Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/323899 · Cited by 95
Calderwood, S. A., Wennersten, C. B., Moellering, R. C., Kunz, L. J., & Krogstad, D. J. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.401 · Cited by 94
Murray, B. E., Mederski-Samoraj, B., Foster, S. K., et al. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112289 · Cited by 92
Self-citationEnoch, D., Bygott, J. M., Daly, M., & Karas, J. A. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.05.180 · Cited by 85
Arias, C. A., Torres, H. A., Singh, K. V., Panesso, D., Moore, J. E., Wanger, A. R., & Murray, B. E. (2007) · Clinical Infectious Diseases · doi:10.1086/522656 · Cited by 84
Self-citationWerner, G., Gfrörer, S., Fleige, C., Witte, W., & Klare, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn065 · Cited by 84
Dose Dependence of Emergence of Resistance to Linezolid inEnterococcus faecalisIn Vivo
Bourgeois‐Nicolaos, N., Massias, L., Couson, B., Butel, M., Andremont, A., & Doucet‐Populaire, F. (2007) · The Journal of Infectious Diseases · doi:10.1086/513876 · Cited by 83
Endocarditis Due to Vancomycin-Resistant Enterococci: Case Report and Review of the Literature
Stevens, M., & Edmond, M. B. (2005) · Clinical Infectious Diseases · doi:10.1086/444459 · Cited by 82
Pankey, G. A., Ashcraft, D. S., & Patel, N. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5166-5168.2005 · Cited by 82
Novel aerobic tetracycline resistance gene that chemically modifies tetracycline
Speer, B. S., & Salyers, A. A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.1.148-153.1989 · Cited by 81
Bonora, M. G., Solbiati, M., Stepan, E., Zorzi, A., Luzzani, A., Catania, M. R., & Fontana, R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.1153-1155.2006 · Cited by 81
Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis
Murphy, T. M., Deitz, J. M., Petersen, P. J., Mikels, S. M., & Weiss, W. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3022-3027.2000 · Cited by 80
Lobritz, M. A., Hutton‐Thomas, R., Marshall, S. H., & Rice, L. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3318-3320.2003 · Cited by 78
Dobbs, T. E., Patel, M., Waites, K. B., Moser, S. A., Stamm, A. M., & Hoesley, C. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00850-06 · Cited by 78
Donskey, C. J., Hanrahan, J., Hutton, R. A., & Rice, L. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315428 · Cited by 76
Jensen, L. B., Hammerum, A. M., Aarestrup, F. M., van den Bogaard, A. E. J. M., & Stobberingh, E. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3330 · Cited by 75
Critchley, I. A., Blosser-Middleton, R. S., Jones, M. E., Thornsberry, C., Sahm, D. F., & Karlowsky, J. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1689-1693.2003 · Cited by 75
Mechanisms of Resistance to Daptomycin in Enterococcus faecium
Montero, C. I., Stock, F., & Murray, P. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-07 · Cited by 74
Werner, G., & Witte, W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1813 · Cited by 73
Matsumura, S., & Simor, A. E. (1998) · Clinical Infectious Diseases · doi:10.1086/517755 · Cited by 73
Daptomycin-Resistant Enterococcus faecium in a Patient With Acute Myeloid Leukemia
Long, J. K., Choueiri, T. K., Hall, G. S., Avery, R. K., & Sekeres, M. A. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1215 · Cited by 71
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
Streit, J. M., Sader, H. S., Fritsche, T. R., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.03.004 · Cited by 69
Caron, F., Kitzis, M.-D., Gutmann, L., Crémieux, A., Maziere, B., Vallois, J. M., Saleh‐Mghir, A., Lemeland, J. F., & Carbon, C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2611 · Cited by 69
Zervos, M. J., & Schaberg, D. R. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.446 · Cited by 68
Brandt, C. M., Rouse, M. S., Laue, N. W., Stratton, C. W., Wilson, W. R., & Steckelberg, J. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.4.909 · Cited by 64
AMINOGLYCOSIDE RESISTANT ENTEROCOCCAL ENDOCARDITIS
Eliopoulos, G. M. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30509-2 · Cited by 63
Ruggero, K. A., Schroeder, L. K., Schreckenberger, P. C., Mankin, A. S., & Quinn, J. P. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00153-6 · Cited by 62
Optimal therapy for enterococcal endocarditis
Herzstein, J., Ryan, J. L., Mangi, R. J., Greco, T. P., & Andriole, V. T. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90772-1 · Cited by 62
Dina, J., Malbruny, B., & Leclercq, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2307-2309.2003 · Cited by 61
Jenkins, I. (2007) · Journal of Hospital Medicine · doi:10.1002/jhm.236 · Cited by 61
Pogue, J. M., Paterson, D. L., Pasculle, A. W., & Potoski, B. A. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/523276 · Cited by 59
Werner, G., Klare, I., & Witte, W. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01691571 · Cited by 58
Arias, C. A., Singh, K. V., Panesso, D., & Murray, B. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-07 · Cited by 55
Self-citationRAAD, I. I., Hanna, H. A., Hachem, R. Y., Dvorak, T. L., Arbuckle, R. B., Chaiban, G., & Rice, L. B. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3583-3585.2004 · Cited by 55
Isolated Pulmonic Valve Infective Endocarditis: A Persistent Challenge
Hamza, N. A., Ortiz, J., & Bonomo, R. A. (2004) · Infection · doi:10.1007/s15010-004-3022-3 · Cited by 54
Gales, A. C., Sader, H. S., & Jones, R. N. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01051.x · Cited by 49
A Novel Mechanism of Resistance to Penicillin-Gentamicin Synergism in Streptococcus faecalis
Moellering, R. C., Murray, B. E., Schoenbaum, S. C., Adler, J. L., & Wennersten, C. B. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.1.81 · Cited by 49
Self-citationEvaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model
Arias, C. A., Singh, K. V., Panesso, D., & Murray, B. E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm237 · Cited by 49
Self-citationTsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., & Baddour, L. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02188-06 · Cited by 48
Self-citationWhitman, M. S., Pitsakis, P. G., Zausner, A., et al. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2069 · Cited by 48
Singh, K. V., & Murray, B. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.32-39.2005 · Cited by 47
Self-citationLeonard, S. N., & Rybak, M. J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.458 · Cited by 46
Fantin, B., Leclercq, R., Garry, L., & Carbon, C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.931 · Cited by 45
Ang, J. Y., Lua, J. L., Turner, D. R., & Asmar, B. I. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000101784.83146.0c · Cited by 44
Fantin, B., Leclercq, R., Ottaviani, M., Vallois, J. M., Maziere, B., Duval, J., Pocidalo, J. J., & Carbon, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.432 · Cited by 44
In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe
Jansen, W. T. M., Verel, A., Verhoef, J., & Milatović, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00100-07 · Cited by 44
The streptogramin antibiotics: update on their mechanism of action
Beyer, D., & Pepper, K. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.591 · Cited by 42
Wareham, D. W., Abbas, H., Karcher, A. M., & Das, S. S. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.05.022 · Cited by 41
Enterococcus faecalis Resistant to Linezolid: Case Series and Review of the Literature
Burleson, B. S., Ritchie, D. J., Micek, S. T., & Dunne, W. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1225.38086 · Cited by 40
Havard, C. W. H., GARROD, L. P., & WATERWORTH, P. M. (1959) · BMJ · doi:10.1136/bmj.1.5123.688 · Cited by 39
Failure of Linezolid Treatment for Enterococcal Endocarditis
Zimmer, S. M., Caliendo, A., Thigpen, M. C., & Somani, J. (2003) · Clinical Infectious Diseases · doi:10.1086/375877 · Cited by 38
Successful Treatment ofEnterococcus faecalisProsthetic Valve Endocarditis with Linezolid
Rao, N., & White, G. J. (2002) · Clinical Infectious Diseases · doi:10.1086/342572 · Cited by 38
Bingen, É., Lambert-Zechovsky, N., Leclercq, R., Doit, C., & Mariani‐Kurkdjian, P. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.5.619 · Cited by 38
Nannini, E. C., Pai, S. R., Singh, K. V., & Murray, B. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.529-532.2003 · Cited by 37
Self-citationVancomycin-Resistant Staphylococcus aureus: A Perfect but Geographically Limited Storm?
Tenover, F. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527393 · Cited by 36
Rice, L. B., Eliopoulos, G. M., & Moellering, R. C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.470 · Cited by 36
De Novo Daptomycin Nonsusceptibility in a Clinical Isolate
Lesho, E. P., Wortmann, G. W., Craft, D. W., & Moran, K. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.673.2006 · Cited by 35
Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis
Hidron, A. I., Schuetz, A. N., Nolte, F. S., Gould, C. V., & Osborn, M. K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn105 · Cited by 35
Hayden, M. K., Koenig, G. I., & Trenholme, G. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1225 · Cited by 34
Schwartz, B. S., Ngo, P. D., & Guglielmo, B. J. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k548 · Cited by 33
Tripodi, M., Locatelli, A., Adinolfi, L. E., Andreana, A., & Utili, R. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050171 · Cited by 33
Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis
Tomayko, J. F., Zscheck, K. K., Singh, K. V., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1170 · Cited by 31
Self-citationInfective endocarditis caused by daptomycin-resistant Enterococcus faecalis: A case report
Kanafani, Z. A., Federspiel, J. J., & Fowler, V. G. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600786465 · Cited by 30
Hexapeptide Derivatives of Glycopeptide Antibiotics: Tools for Mechanism of Action Studies
Allen, N. E., LeTourneau, D. L., Hobbs, J. N., & Thompson, R. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2344-2348.2002 · Cited by 30
Green, M. R., Anasetti, C., Sandin, R. L., Rolfe, N. E., & Greene, J. N. (2006) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155206069165 · Cited by 28
Archuleta, S., Murphy, B. T., & Keller, M. J. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00059.x · Cited by 28
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin
Fraher, M., Corcoran, G. D., Creagh, S., & Feeney, E. R. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.01.002 · Cited by 26
Carrier, D., Khalil, M. B., & Kealey, A. (1998) · Biochemistry · doi:10.1021/bi971793d · Cited by 22
Overview of tigecycline and its role in the era of antibiotic resistance
Rossi, F., & Andreazzi, D. (2006) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702006000300010 · Cited by 21
Antony, S. J., Ladner, J. M., Stratton, C. W., Raudales, F., & Dummer, S. J. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709035908 · Cited by 21
Landman, D., Quale, J. M., Mobarakai, N. K., & Zaman, M. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.1.253 · Cited by 20
Sacher, H. L., Miller, W. C., Landau, S. W., Sacher, M. L., Dixon, W. A., & Dietrich, K. A. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03766.x · Cited by 15
Outbreak ofEnterococcus gallinarumInfections After Total Knee Arthroplasty
Cooper, M. P., Lessa, F. C., Brems, B., et al. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/529213 · Cited by 14
Tascini, C., Doria, R., Leonildi, A., Martinelli, C., & Menichetti, F. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.4.400 · Cited by 13
El-Mady, A., & Mortensen, J. E. (1991) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(91)90049-l · Cited by 12
Emergence of Enterococcus faecalis susceptible to quinupristin/dalfopristin in Greece
Petinaki, E., Kontos, F., Maniatis, A. N., Spiliopoulou, I. T., & Liakos, P. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.04.002 · Cited by 7
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Self-citationAntibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
Self-citationISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
Li, P. K.-T., Szeto, C. C., Piraino, B., de Arteaga, J., Fan, S., Figueiredo, A. E., Fish, D. N., Goffin, E., Kim, Y.-L., Salzer, W., et al. (2016) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2016.00078 · Cited by 907
Peritoneal Dialysis-Related Infections Recommendations: 2010 Update
Li, P. K.-T., Szeto, C. C., Piraino, B., Bernardini, J., Figueiredo, A. E., Gupta, A., Johnson, D. W., Kuijper, E. J., Lye, W.-C., Salzer, W., et al. (2010) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2010.00049 · Cited by 887
Metadata
- Authors
- Arias, C. A., & Murray, B. E.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2008-10
- Volume
- 6
- Issue
- 5
- Pages
- 637-655
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W2103638912
- Cited by
- 294
- References
- 184
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.